Ignite Creation Date:
2025-12-24 @ 11:53 PM
Ignite Modification Date:
2026-05-17 @ 1:00 PM
Study NCT ID:
NCT04853251
Status:
RECRUITING
Last Update Posted:
2025-12-22
First Post:
2021-04-16
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study Assessing Corneal Endothelial Cells in Participants With Neovascular Age-related Macular Degeneration (nAMD) Treated With the Port Delivery System With Ranibizumab (PDS)
Sponsor:
Genentech, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ML43000
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None